Denis Tsygankov, PhD, is Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. 

Dr. Tsygankov is interested in developing and applying computational methods, including mathematical modeling, simulations, and computer vision approaches to understand complex multi-scale physiological processes including vasculogenesis, morphogenesis, and cancer. 

He is a member of the Cell and Molecular Biology Research Program at Winship Cancer Institute.

Dr. Johnna S. Temenoff is the Carol Ann and David D. Flanagan Professor at the Coulter Department of Biomedical Engineering at Georgia Tech/Emory University. She is also currently the Director of the NSF Engineering Research Center in Cell Manufacturing Technologies (CMaT) and the Director of the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M). Scientifically, Dr. Temenoff is interested in scaling culture of therapeutic cells and tailoring the molecular interactions between glycosaminoglycans and proteins/cells for use in regenerative medicine applications.  Her laboratory focuses primarily on promoting repair after injuries to the tissues of the shoulder, including cartilage, tendon, and muscle.

Dr. Temenoff has been honored with several prestigious awards, such as the NSF CAREER Award, Arthritis Foundation Investigator Award, and Society for Biomaterials (SFB) Clemson Award for Contributions to the Literature, and was named to the College of Fellows of the American Institute for Medical and Biological Engineers (AIMBE), as a Fellow of the Biomedical Engineering Society (BMES), as a Fellow of the International Academy of Medical and Biological Engineering (IAMBE) and as a Fellow of Biomaterials Science and Engineering, International Union of Societies for Biomaterials Science and Engineering (IUSBSE).  She has co-authored a highly successful introductory textbook - Biomaterials: The Intersection of Biology and Materials Science, by J.S. Temenoff and A.G. Mikos (now in a 2nd edition), for which Dr. Temenoff and Dr. Mikos were awarded the American Society for Engineering Education’s Meriam/Wiley Distinguished Author Award for best new engineering textbook. 

Garrett Stanley is the McCamish Foundation Distinguished Chair in the Department of Biomedical Engineering at Georgia Tech and Emory University and is the Co-Director of the Georgia Tech Neural Engineering Center. He has formal training, both at undergraduate and doctorate levels, in engineering (specifically trained in Control Theory through all of his graduate work), and has worked extensively in the field of neuroscience, specifically in sensory processing in the brain, and more specifically in vision and somatosensation (touch). 

From 1999 to 2007, he was an Associate Professor in the Division of Engineering & Applied Sciences at Harvard University, where he was the leader of the Harvard Biocontrols Laboratory. Professor Stanley is now a faculty member in the Department of Biomedical Engineering at Georgia Tech/Emory University (2008-2013 Associate Professor, 2014-present Full Professor), and leads several programmatic efforts at the interface between basic neuroscience and neurotechnology (Co-Direct the GT Neural Engineering Center, Direct Computational Neuroscience training program, Director of Graduate Studies, etc.). In terms of research, he is the leader of the Neural Coding group in the Laboratory for Neuroengineering. 

The research of his group has been funded by the National Institute of Health, National Science Foundation, the Office of Naval Research, DARPA, and several private foundations. Prof. Stanley’s group routinely publishes our research in the top Neuroscience journals, along with more technical work in engineering journals. He is considered a leader in the field nationally and internationally.

The central goal of Dr. Singer’s research program is to understand how neural activity produces memories and spurs the brain’s immune system. Dr. Singer’s research integrates innovative behavioral, electrophysiological, and computational methods to identify and restore failures in neural activity that lead to memory impairment. Dr. Singer has established and continues to develop a new therapeutic approach to Alzheimer’s disease, novel forms of non-invasive stimulation, and new ways to manipulate the brain’s immune system. Additionally, using non-invasive approaches, she is translating her discoveries from rodents to develop radically new ways to treat diseases that affect memory in humans.

Aniruddh Sarkar is an Assistant Professor in the Wallace H. Coulter Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University where he leads the Micro/Nano Bioelectronics Lab. He was earlier a Research Fellow at the Ragon Institute of MGH, MIT and Harvard with research affiliations at Harvard Medical School and at MIT. His research has evolved around the theme of exploiting unique physical phenomena that occur at the micrometer to nanometer length scales to develop devices and systems for solving various technological problems with a special focus on applications in biology and medicine. His earlier work, with Prof. Galit Alter (MGH/HMS) and Prof. Jongyoon Han (MIT), involved the development and application of microfabricated and nanofabricated devices to further the prevention, diagnosis and therapy of infectious diseases such as Tuberculosis and HIV/AIDS. He received his Ph.D in Electrical Engineering and Computer Science with a minor in Biology at MIT, developing microfluidic tools for single-cell analysis. He received his bachelors and masters degrees, both in Electrical Engineering at IIT Bombay.

Philip Santangelo is a professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. He is a member of the Cancer Immunology Research Program at Winship Cancer Institute. 

Dr. Santangelo obtained his Ph.D. in Engineering from the University of California at Davis. He completed his postdoctoral training at Sandia National Laboratories in Livermore, California and at Georgia Tech in Atlanta, Georgia. He also holds an MS in Engineering from Purdue University. 

The overarching theme of the Santangelo lab is the spatial biology of RNA viruses and RNA regulation. Spatial biology is the study of biology in three dimensions — and the Santangelo lab develops advanced imaging tools to achieve this goal. The lab focuses their tools on the spatial biology of HIV/SIV and human respiratory synctial virus (leading cause of bronchiolitis and pneumonia in babies) and the aberrant regulation of messenger RNA during inflammation, viral infections and cancer pathogenesis. They have developed both single molecule methods and whole body imaging methods in order to work towards our goals.

Since joining the faculty in 2012, James Rains has taught two of Tech’s most critical classes for creating the next generation of biomedical engineers. “Intro to Biomedical Engineering Design” and the “Biomedical Engineering Capstone” courses are bookends on the student experience in the BME program, which has consistently ranked among the best in the nation. Meanwhile, Rains helps give students more real-world healthcare problems from clinicians and medical companies than any other BME department in the world. He constantly strives to find the best and most diverse projects for his students, including in 2018, a new collaboration with the world-renowned Mayo Clinic. His BME student teams consistently win top honors in innovation competitions and mentors and coaches Create-X student startups. For all of his tremendous efforts, he was named the 2019 Undergraduate Educator of the Year by Tech’s Center for Teaching and Learning.

Peng Qiu is an Associate Professor in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech School of Engineering and Emory University School of Medicine. 

Dr. Qiu is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He received his Ph.D. in Electrical and Computer Engineering from University of Maryland in College Park, Maryland. 

His research interests are in the areas of bioinformatics and computational biology with a focus on statistical signal processing, machine learning, control systems and optimization. 

As it relates to cancer, he is interested in single-cell analysis, and multi-omics pan-cancer data integration. He is collaborating with Winship investigator Adam Marcus on the analysis of single-cell RNAseq data of leader/follower cells in experiments that study the behavior of collective invasion in cancer.

Erik C. Dreaden joined the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University in 2017. Dr. Dreaden also holds a joint faculty appointment in the Department of Pediatrics at the Emory University School of Medicine where he collaborates with researchers at Children's Healthcare of Atlanta and the Aflac Center for Cancer and Blood Disorders. Dr. Dreaden's research seeks to apply principles of molecular and nanoscale engineering to improve the therapeutic potential of drug combinations, vaccines, and immunotherapies directed against pediatric and adult cancers. 

Prior to joining Emory and Georgia Tech, Dr. Dreaden was a postdoctoral fellow at the Koch Institute for Integrative Cancer Research at MIT, where his research focused on the development of polymer-based technologies for nucleic acid and rational combination cancer therapies. 

Dr. Dreaden is a member of the Cancer Immunology Research Program at the Winship Cancer Institute of Emory University. He also holds memberships in the Biomedical Engineering Society, American Institute of Chemical Engineers, American Association of Cancer Research, Materials Research Society, American Association for the Advancement of Science, and American Chemical Society.